|
TMOD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.33130000001813E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.49079999958823E-07 |
| Normal-vs-Stage2 |
3.821300E-03 |
| Normal-vs-Stage3 |
2.216400E-01 |
| Normal-vs-Stage4 |
2.268800E-01 |
| Stage1-vs-Stage2 |
7.765000E-01 |
| Stage1-vs-Stage3 |
3.214300E-02 |
| Stage1-vs-Stage4 |
3.129600E-01 |
| Stage2-vs-Stage3 |
1.751180E-01 |
| Stage2-vs-Stage4 |
4.514600E-01 |
| Stage3-vs-Stage4 |
7.277800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.12590000000967E-06 |
| Normal-vs-AfricanAmerican |
2.08549999999308E-05 |
| Normal-vs-Asian |
2.726000E-01 |
| Caucasian-vs-AfricanAmerican |
9.123200E-01 |
| Caucasian-vs-Asian |
8.931400E-01 |
| AfricanAmerican-vs-Asian |
8.437200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.1725000039844E-08 |
| Normal-vs-Female |
3.185800E-02 |
| Male-vs-Female |
5.604500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.366200E-04 |
| Normal-vs-Extreme_Weight |
1.03110000537754E-08 |
| Normal-vs-Obese |
3.456300E-03 |
| Normal-vs-Extreme_Obese |
1.820000E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.372800E-01 |
| Normal_Weight-vs-Obese |
4.890800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.415000E-01 |
| Extreme_Weight-vs-Obese |
4.955900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.785200E-01 |
| Obese-vs-Extreme_Obese |
5.366600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.277700E-02 |
| Normal-vs-Age(41-60Yrs) |
8.23980000000946E-05 |
| Normal-vs-Age(61-80Yrs) |
4.1658000005107E-07 |
| Normal-vs-Age(81-100Yrs) |
5.206400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.564400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.112000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.400400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.233180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.649400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.467000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.40779999879825E-08 |
| Normal-VS-Type2 PRCC |
1.438380E-02 |
| Normal-VS-KIRP CIMP |
7.228600E-01 |
| Normal-VS-Unclassified PRCC |
1.478390E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.233900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.038100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.382200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.682800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.181800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.384200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.5115199999971E-05 |
| Normal-vs-N1 |
2.044600E-01 |
| Normal-vs-N2 |
4.304600E-01 |
| N0-vs-N1 |
6.137700E-02 |
| N0-vs-N2 |
6.884200E-01 |
| N1-vs-N2 |
6.661800E-01 |
|
|
